Email this article to a friend
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
-
* Corresponding author: Jose A Lopez-Guerrero jalopez@fivo.org
- † Equal contributors
BMC Cancer 2010, 10:36 doi:10.1186/1471-2407-10-36